🔥🐔 BizChicken 🐔🔥
Companies Similar to Ginkgo Bioworks Holdings, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Bio-Path Holdings, Inc.
DNAbilize
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused RNAi nano particle drug development company, developing products based on the DNAbilize technology. The company is advancing its lead drug candidate, prexigebersen, for the treatment of AML and myelodysplastic syndrome.
Symbol: BPTH
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. Peter H. Nielsen MBA
Sector: Healthcare
Employees: 10
Address: 4710 Bellaire Boulevard, Bellaire, TX 77401
Phone: 832 742 1357
Leadership
- Peter Nielsen, Chief Executive Officer, Chief Financial Officer
- Ana Tari Ashizawa, PhD, MBA, Senior Vice President of Research, Development & Clinical Design
- Anthony Price, MBA, Senior Vice President of Finance, Accounting & Administration
- Michael Hickey, MBA, Vice President of Clinical Operations
- Michael Roberts, Director of Manufacturing Planning & Engineering
- Chairman of the Board,
- President,
- Heath Cleaver, Director
- Paul Aubert, Director
- Douglas P. Morris, Director
- Aline Sherwood, Director
Last updated: 2024-12-31
Passage Bio, Inc.
PBGM01, PBFT02, PBKR03, PBML04, PBAL05, PBCM06
Passage Bio, Inc. develops transformative therapies for central nervous system diseases using proprietary genetic medicine technologies to deliver functional genes for the treatment of various disorders.
Symbol: PASG
Recent Price: $0.67
Industry: Biotechnology
CEO: Dr. William Chou M.D.
Sector: Healthcare
Employees: 58
Address: One Commerce Square, Philadelphia, PA 19103
Phone: 267 866 0311
Leadership
- William Chou, MD, President and Chief Executive Officer
- Kathleen Borthwick, Chief Financial Officer
- Sue Browne, PhD, Chief Scientific Officer
- Edgar B. (Chip) Cale, General Counsel and Corporate Secretary
- Eden Fucci, SVP Technical Operations
- Stuart Henderson, Chief Business Officer
- Karl Whitney, PhD, SVP Global Regulatory Affairs
- James M. Wilson, MD, PhD, Scientific Advisor
- Maxine Gowen, PhD, Chairwoman
- Athena Countouriotis, MD,
- Derrell D. Porter, MD,
- Dolan Sondhi, PhD,
- Sandip Kapadia,
- Tom Kassberg,
- Saqib Islam,
- Samiah Al-Zaidy, MD, Vice President, Clinical Development
- Andrea Campanile, Vice President, Clinical Operations
Last updated: 2024-12-31
GeneDx Holdings Corp.
Centrellis health intelligence platform
Gene Dx Holdings Corp. is a patient-centered health intelligence company focused on transforming healthcare by leveraging AI and machine learning on clinical and genomic data to improve individual health outcomes.
Symbol: WGS
Recent Price: $76.58
Industry: Medical - Healthcare Information Services
CEO: Ms. Katherine A. Stueland
Sector: Healthcare
Employees: 1000
Address: North Tower, Stamford, CT 06902
Phone: 800 298 6470
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Day One Biopharmaceuticals, Inc.
DAY101
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for genetically defined cancers. Their lead product candidate is DAY101, currently in Phase II clinical trials for pediatric patients with low-grade glioma.
Vision/Values | Leadership | About | Contact | About | Leadership | Leadership | Leadership | Leadership | Leadership | About | About
Symbol: DAWN
Recent Price: $12.58
Industry: Biotechnology
CEO: Dr. Jeremy Bender M.B.A., Ph.D.
Sector: Healthcare
Employees: 174
Address: 395 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 484 0899
Leadership
- Samuel Blackman, MD, PhD, Head of R&D
- Elly Barry, MD, Chief Medical Officer
- Jeremy Bender, PhD, MBA, Director
- Davy Chiodin, PharmD, Chief Development Officer
- Adam Dubow, General Counsel
- Lauren Merendino, MBA, Chief Commercial Officer
- John Stubenrauch, Chief Technology Officer
- Jaa Roberson, Chief People Officer
- Charles N. York II, MBA, Chief Operating and Financial Officer
- Garry Nicholson, MBA, Chair
- Habib Dable, Director
- Scott Garland, Director
- Michael Gladstone, Director
- William Grossman, MD, PhD, Director
- Natalie Holles, Director
- John A. Josey, PhD, MBA, Director
- Saira Ramasastry, MS, MPhil, Director
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
Harvard Bioscience, Inc.
cellular and molecular technology instruments
Harvard Bioscience, Inc. develops, manufactures, and sells technologies and services that support research, discovery, and pre-clinical testing for drug development globally, offering a wide range of instruments for tissue and organ-based lab research.
About | Vision/Values | Leadership | Contact | About | Contact | Contact | Careers | About | About | About | About | About | About | About | About | About | About | About | Careers | About | About
Symbol: HBIO
Recent Price: $2.02
Industry: Medical - Instruments & Supplies
CEO: Mr. James W. Green
Sector: Healthcare
Employees: 391
Address: 84 October Hill Road, Holliston, MA 01746
Phone: 508 893 8999
Leadership
- James Green, Chairman, President & Chief Executive Officer
- Jennifer Cote, Chief Financial Officer and Treasurer
- John Fry, Chief Legal Counsel and Corporation Secretary
- Diane Houston, Vice President, Global IT
- Lori Packer, Vice President, Global People Operations
- Nitya Shetty, Vice President, Global Research and Development
- Ryan Wallace, Senior Vice President, Global Sales
Last updated: 2024-12-31
Leafly Holdings, Inc.
Leafly Platform
Leafly Holdings, Inc. provides consumers with cannabis information, connecting them with brands and licensed retailers. The platform offers marketplace listings, digital advertising, SaaS tools for retailers, and consumer information via its website and mobile applications.
Symbol: LFLY
Recent Price: $1.53
Industry: Medical - Pharmaceuticals
CEO: Ms. Yoko Miyashita
Sector: Healthcare
Employees: 121
Address: 111 South Jackson Street, Seattle, WA 98104
Phone: 206 455 9504
Last updated: 2024-12-31
NeuroBo Pharmaceuticals, Inc.
ANA001
A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.
Symbol: NRBO
Recent Price: $2.36
Industry: Biotechnology
CEO: Mr. Hyung-Heon Kim
Sector: Healthcare
Employees: 8
Address: 200 Berkeley Street, Boston, MA 02116
Phone: 857 702 9600
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Omega Therapeutics, Inc.
OMEGA Epigenomic Programming platform
Omega Therapeutics, Inc. is a development-stage biopharmaceutical company leveraging its OMEGA Epigenomic Programming platform to utilize the power of epigenetics for therapeutic interventions across various diseases.
About | Vision/Values | Leadership | Leadership | About | Contact | Contact | About | About
Symbol: OMGA
Recent Price: $0.80
Industry: Biotechnology
CEO: Mr. Mahesh Karande
Sector: Healthcare
Employees: 93
Address: 20 Acorn Park Drive, Cambridge, MA 02140
Phone: 617 949 4360
Leadership
- Mahesh Karande, President & Chief Executive Officer
- Kaan Certel, Ph.D., Chief Business Officer
- Jennifer Nelson, Ph.D., Senior Vice President, Research
- Tony Mullin, Chief People Officer
- Barbara Chan, Senior Vice President, Finance and Chief Accounting Officer
- Lisamarie Fahy, Senior Vice President, Clinical Development Operations
- Joe Newman, Ph.D., Senior Vice President, Early Discovery
- Jeff Atkinson, Ph.D., Vice President, Technical Operations
- Eva Stroynowski, Senior Vice President, Investor Relations and Corporate Affairs
Last updated: 2024-12-31
Organovo Holdings, Inc.
Novo Gen Bioprinters
Organovo Holdings, Inc. is a biotechnology company that develops 3D tissues to model human diseases, utilizing proprietary bioprinting technologies such as Novo Gen Bioprinters for fabricating living tissues.
About | About | About | About | Leadership | Directors | Contact | Contact | Contact | Careers
Symbol: ONVO
Recent Price: $0.36
Industry: Biotechnology
CEO: Mr. Keith E. Murphy
Sector: Healthcare
Employees: 20
Address: 11555 Sorrento Valley Road, Solana Beach, CA 92121
Phone: 858 224 1000
Leadership
- Keith Murphy, Executive Chairman, CEO
- Thomas P. Hess, Chief Financial Officer
- Curtis Tyree, Ph.D., Senior Vice President, Strategy and Business Development
- Adam K. Stern, CEO
- Alison Milhous, Vice President, Accounting
- David Gobel, CEO
- Doug Cohen, President and Chief Executive Officer
- Vaidehi Joshi, Director of Discovery Biology
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
BioLife Solutions, Inc.
bioproduction tools and services
Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.
About | Events | Leadership | Leadership | Management | About | About | News | Contact | Contact | Contact | Contact | Contact | About | About | About | About | About
Symbol: BLFS
Recent Price: $26.27
Industry: Medical - Instruments & Supplies
CEO: Mr. Roderick de Greef
Sector: Healthcare
Employees: 409
Address: 3303 Monte Villa Parkway, Bothell, WA 98021
Phone: 425 402 1400
Leadership
- Rod de Greef, Chairman & Chief Executive Officer
- Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
- Karen Foster, Chief Quality and Operations Officer
- Troy Wichterman, Chief Financial Officer
- Todd Berard, Chief Marketing Officer
- Garrie Richardson, Chief Revenue Officer
- Sarah Aebersold, Chief Human Resources Officer
- Mike Pallotta, Global VP, Hardware and Electrical Engineering
- Brett Stucker, VP of Cybersecurity and Information Security Officer
- Amy DuRoss,
- Rachel Ellingson,
- Joydeep Goswami, MBA, Ph.D.,
- Tim Moore,
- Joseph Schick, Chairman – Audit Committee
- Andrew Hinson,
- Anthony Davies, Ph.D.,
- Colleen Delaney, M.D., M.Sc.,
- Dayong Gao, Ph.D.,
- Erik Woods, Ph.D., HCLD(ABB),
- Jon Rowley, Ph.D.,
- John McMannis, Ph.D.,
- Jerry E. Cooley, M.D.,
- Jason Acker, MBA, Ph.D.,
- Lizabeth Cardwell, MT (ASCP), MBA, RAC,
- Scott R. Burger, M.D.,
- Shelly Heimfeld, Ph.D.,
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
IN8bio, Inc.
INB-200, INB-100, INB-400, INB-300
IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.
Symbol: INAB
Recent Price: $0.27
Industry: Biotechnology
CEO: Mr. Tai-Wei Ho
Sector: Healthcare
Employees: 39
Address: 350 5th Avenue, New York, NY 10118
Phone: 646 600 6438
Last updated: 2024-12-31